Dolby Laboratories, Inc. (NYSE:DLB ) Q1 2025 Earnings Conference Call January 29, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - President, CEO & Director Robert Park - SVP & CFO Conference Call Participants Steven Frankel - Rosenblatt Securities Patrick Sholl - Barrington Research Ralph Schackart - William Blair Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing First Quarter Fiscal Year 2025 results.
Dolby Laboratories (DLB) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago.
DLB's fiscal first-quarter performance is likely to have gained from momentum across Dolby Atmos and Dolby Vision amid soft device sales.
Dolby Laboratories (DLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investments in cutting-edge and innovative solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and GPRO amid cautious discretionary spending.
DLB gains from strength in Dolby Atmos and Dolby Vision. However, a downtrend at the box office and weak global consumer electronics sales are concerns.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Dolby Laboratories reported strong Q4 and FY 2024 results, with significant improvements in revenue, operating income, and free cash flow, boosting the stock by over 15%. Management highlights growth opportunities in Dolby Atmos, Dolby Vision, and the GE Licensing acquisition, projecting 4.5-9% revenue growth for FY 2025. Despite solid performance, the stock remains overvalued, trading at high multiples, requiring 10% annual growth for fair valuation, which seems unlikely.
DLB's fiscal Q4 2024 performance gains from steady growth in the Licensing business amid softness in the Products and services segments.
While the top- and bottom-line numbers for Dolby Laboratories (DLB) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.